International Centre For Diarrhoeal Disease Research, Bangladesh

This trial tests whether an oral antibiotic called tebipenem-pivoxil works as well as the standard IV antibiotic ceftriaxone for children with shigellosis, a severe diarrheal disease, when first-line treatment fails. The study enrolls children aged 24 to 59 months who have not im…

This trial tests whether a microbiota-directed food (MDF) can enhance immunity in severely malnourished children better than standard zinc with micronutrient powder and khichuri. Children aged 6-36 months who have recovered from acute infection will receive either MDF or the stan…

This early study tested whether the drug ivermectin could safely treat post-kala-azar dermal leishmaniasis (PKDL), a skin condition that can appear after recovery from visceral leishmaniasis. Ten otherwise healthy adults with PKDL took ivermectin pills for five days each month fo…

This early study tested whether the common anti-parasite drug ivermectin could treat post-kala-azar dermal leishmaniasis (PKDL), a skin condition that can spread a serious disease. Thirty people in Bangladesh received either ivermectin pills for 3 months or the standard drug milt…

This study follows 599 mother-child pairs in Bangladesh who received parenting training and unconditional cash support when the children were infants. Now aged 6-9, the children are tested for IQ, reading, and math skills to see if the early help still makes a difference. The goa…